|   | (Mark One)                                                                                         |
|--------|----------------------------------------------------------------------------------------------------|
| R      | QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934             |
|   |                                                                                               |
|   | For the quarterly period ended March 31, 2009                                                      |
|   | or                                                                                                 |
|   |                                                                                               |
| £ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934           |
|   |                                                                                               |
|   | For the transition period from           to |

| Delaware                        | 56-1764501          |
|---------------------------------|---------------------|
| (State or other jurisdiction of | (I.R.S. Employer    |
| incorporation or organization)  | Identification No.) |

----

|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|-----------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | Page   |
| PART I   FINANCIAL INFORMATION |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Item 1                                        | Condensed Consolidated Financial Statements                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |   |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|                                          | Condensed Consolidated Balance Sheets as of March 31, 2009 (Restated) (unaudited) and December 31, 2008                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 4      |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|                                          | Condensed Consolidated Statements of Operations for the Three Months ended March 31, 2009 (Restated) and 2008 (unaudited)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 5      |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|                                          | Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three Months ended March 31, 2009 (Restated) (unaudited)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 6      |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|                                          | Condensed Consolidated Statements of Cash Flows for the Three Months ended March 31, 2009 (Restated) and 2008 (unaudited)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 7      |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
|                                          | Notes to Condensed Consolidated Financial Statements (unaudited)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | 8      |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 2                                        | Management’s Discussion and Analysis of Financial Condition and Results of Operations                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 17     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 3                                        | Quantitative and Qualitative Disclosures About Market Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 20     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 4T                                       | Controls and Procedures                                                                                                                                                        | 20     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| PART II OTHER INFORMATION                     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Item 1                                        | Legal Proceedings                                                                                                                                                              | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 1A                                       | Risk Factors                                                                                                                                                                   | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 2                                        | Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                    | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 3                                        | Defaults Upon Senior Securities                                                                                                                                                | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 4                                        | Submission of Matters to a Vote of Security Holders                                                                                                                            | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 5                                        | Other Information                                                                                                                                                              | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |   |
| Item 6                                        | Exhibits                                                                                                                                                                       | 22     |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| SIGNATURES                                    | 19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|                                          |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| CERTIFICATIONS                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

----

| ●   | Adoption of certain provisions of Accounting Standards Codification (“ASC”) 815 – “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815”) (formerly EITF 07-5, “Determining Whether an Instrument (or Embedded Feature) is Indexed to an Entity’s Own Stock”).  ASC 815 became effective January 1, 2009.  The anti-dilution features in certain outstanding warrants (“Warrants”) of the Company require these Warrants to be accounted for as liabilities and measured at fair value.  The restated condensed consolidated financial statements reflect the reclassification of the Warrants from shareholders’ equity to warrant liability, the cumulative effect adjustment to the opening balance of accumulated deficit and record changes in the fair value of the warrant liability in the condensed consolidated statements of operations. |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ●   | Adoption of the two-class method for Earnings Per Share (“EPS”) calculation under ASC 260, “Earnings Per Share” (“ASC 260”) (formerly “SFAS No. 128”).  The two-class method is an earnings allocation method under which EPS is calculated for each class of common stock and participating security.  Under the two-class method, securities that participate in dividends, such as the Company’s Series B Convertible Preferred stock, are considered ‘participating securities.” The restated financial statements reflect the restated basic and diluted earnings per share, as applicable and weighted average shares outstanding calculations. |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                                                                                                                                                                                                |   |                                           |     |   |              |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|------------------------------------------------|----------|--------|-------------------|--------|
|                                                                                                                                                                                                |   | March 31, 2009(unaudited)(Restated)See Note 15 |     |   | December 31, 2008 |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |
| ASSETS                                                                                                                                                                                              |   |                                           |     |   |              |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |
| Current assets:                                                                                                                                                                                     |   |                                           |     |   |              |   |
| Cash and cash equivalents                                                                                                                                                                           |   | $                                              | 2,329    |   |              | $      | 2,404 |   |
| Investments – held to maturity                                                                                                                                                                |   |                                           | 97       |   |              |   | 97 |   |
| Accounts receivable, net                                                                                                                                                                            |   |                                           | 2,950    |   |              |   | 3,643 |   |
| Inventory                                                                                                                                                                                           |   |                                           | 2,214    |   |              |   | 2,374 |   |
| Prepaid expenses and other current assets                                                                                                                                                           |   |                                           | 1,233    |   |              |   | 796 |   |
| Total current assets                                                                                                                                                                                |   |                                           | 8,823    |   |              |   | 9,314 |   |
| Equipment, furniture and leasehold improvements, net                                                                                                                                                |   |                                           | 391      |   |              |   | 381 |   |
| Intangible assets, net                                                                                                                                                                              |   |                                           | 46       |   |              |   | 47 |   |
| Deferred financing costs, net                                                                                                                                                                       |   |                                           | 212      |   |              |   | 362 |   |
| Total assets                                                                                                                                                                                        |   | $                                              | 9,472    |   |              | $      | 10,104 |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |   |   |
| LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                                                                                                          |   |                                           |     |   |              |   |   |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |   |   |
| Current liabilities:                                                                                                                                                                                |   |                                           |     |   |              |   |   |   |
| Accounts payable                                                                                                                                                                                    |   | $                                              | 569      |   |              | $      | 1,026 |   |
| Accrued compensation                                                                                                                                                                                |   |                                           | 631      |   |              |   | 837 |   |
| Other accrued expenses                                                                                                                                                                              |   |                                           | 1,152    |   |              |   | 804 |   |
| Advance payments                                                                                                                                                                                    |   |                                           | 649      |   |              |   | 694 |   |
| Deferred revenue                                                                                                                                                                                    |   |                                           | 120      |   |              |   | 164 |   |
| Debt                                                                                                                                                                                                |   |                                           | 682      |   |              |   | 1,691 |   |
| Other current liabilities                                                                                                                                                                           |   |                                           | 917      |   |              |   | 798 |   |
| Total current liabilities                                                                                                                                                                           |   |                                           | 4,720    |   |              |   | 6,014 |   |
| Warrant liability                                                                                                                                                                                   |   |                                           | 2,943    |   |              |   | — |   |
| Total liabilities                                                                                                                                                                                   |   | $                                              | 7,663    |   |              | $      | 6,014 |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |   |   |
| Commitments and contingencies                                                                                                                                                                       |   |                                           |     |   |              |   |   |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |   |   |
| Redeemable common stock:  522,500 redeemable shares                                                                                                                                       |   |                                           | 429      |   |              |   | 429 |   |
|                                                                                                                                                                                                |   |                                           |     |   |              |   |   |   |
| Shareholders’ equity:                                                                                                                                                                         |   |                                           |     |   |              |   |   |   |
| Preferred stock, $.001 par value: authorized 10,000,000 shares:                                                                                                                                     |   |                                           | —  |   |              |   | — |   |
|    Series B Convertible Preferred stock, (liquidation preference of $5,739,000) stated value $1,000 per share, $.001 par value:  10,000 shares designated and 5,739 issued      |   |                                           | —  |   |              |   | — |   |
| Common stock, $.001 par value: authorized 200,000,000 shares, issued and outstanding, 15,429,863 shares as of March 31, 2009 and 15,213,959 as of December 31, 2008, net of redeemable common stock |   |                                           | 15       |   |              |   | 15 |   |
| Additional paid-in capital                                                                                                                                                                          |   |                                           | 189,995  |   |              |   | 204,818 |   |
| Accumulated deficit                                                                                                                                                                                 |   |                                           | (188,630 | )      |              |   | (201,172 | ) |
| Total shareholders’ equity                                                                                                                                                                    |   |                                           | 1,380    |   |              |   | 3,661 |   |
| Total liabilities and shareholders’ equity                                                                                                                                                    |   | $                                              | 9,472    |   |              | $      | 10,104 |   |

----

|                                                         |   | Three Months EndedMarch 31,  |       |
|--------------------------------------------------------------|--------|------------------------------|------------|
|                                                         |   | 2009  (Restated) See Note 15 |       |   | 2008 |   |
|                                                         |   |                         |       |   |   |   |
| Revenue:                                                     |   |                         |       |   |   |   |
| Product revenue                                              |   | $                            | 4,356      |   |   | $ | 2,462 |   |
| Contract revenue                                             |   |                         | 788        |   |   |   | 203 |   |
| Total revenue, net                                           |   |                         | 5,144      |   |   |   | 2,665 |   |
|                                                         |   |                         |       |   |   |   |   |   |
| Cost of goods sold:                                          |   |                         |       |   |   |   |   |   |
|   Product revenue                                  |   |                         | 2,257      |   |   |   | 2,181 |   |
|   Contract revenue                                 |   |                         | 428        |   |   |   | 132 |   |
|       Total cost of goods sold |   |                         | 2,685      |   |   |   | 2,313 |   |
| Gross profit                                                 |   |                         | 2,459      |   |   |   | 352 |   |
|                                                         |   |                         |       |   |   |   |   |   |
| Operating expenses:                                          |   |                         |       |   |   |   |   |   |
| Research and development                                     |   |                         | 362        |   |   |   | 674 |   |
| Selling, general and administrative                          |   |                         | 1,529      |   |   |   | 1,807 |   |
| Total operating expenses                                     |   |                         | 1,891      |   |   |   | 2,481 |   |
| Income (loss) from operations                                |   |                         | 568        |   |   |   | (2,129 | ) |
|                                                         |   |                         |       |   |   |   |   |   |
| Other expense:                                               |   |                         |       |   |   |   |   |   |
|   Interest expense, net                            |   |                         | (175       | ) |   |   | (631 | ) |
|   Other income, net                                |   |                         | 1          |   |   |   | 86 |   |
|    Change in fair value of warrant liability       |   |                         | (813       | ) |   |   | — |   |
| Total other expense                                          |   |                         | (987       | ) |   |   | (545 | ) |
| Provision for income taxes                                   |   |                         | —    |   |   |   | — |   |
| Net loss                                                     |   | $                            | (419       | ) |   | $ | (2,674 | ) |
|                                                         |   |                         |       |   |   |   |   |   |
| Loss per share, basic                                        |   | $                            | (0.03      | ) |   | $ | (0.21 | ) |
| Loss per share, diluted                                      |   | $                            | (0.03      | ) |   | $ | (0.21 | ) |
|                                                         |   |                         |       |   |   |   |   |   |
| Weighted average number of shares outstanding:               |   |                         |       |   |   |   |   |   |
|   Basic                                            |   |                         | 15,860,517 |   |   |   | 12,620,900 |   |
| Diluted                                                      |   |                         | 15,860,517 |   |   |   | 12,620,900 |   |

----

|                                                |   | Preferred Stock |    |   | Common Stock |   |    | Additional Paid-in Capital(Restated) |   |   | Accumulated Deficit(Restated) |   |   | Total Shareholders’ Equity(Restated) |    |
|-----------------------------------------------------|--------|-----------------|---------|--------|--------------|--------|---------|--------------------------------------|--------|--------|-------------------------------|--------|--------|--------------------------------------------|---------|
|                                                |   | Shares          |    |   | Amount       |   |    | Shares                               |   |   | Amount                        |   |   | See Note 15                                |    |   | See Note 15 |   |   | See Note 15 |   |
| Balance, December 31, 2008                          |   |            | 6       |   |         | $      | — |                                 |   |   | 15,214                        |   |   | $                                          | 15      |   |   | $ | 204,818 |   |   | $ | (201,172 | ) |   | $ | 3,661 |   |
|                                                |   |            |    |   |         |   |    |                                 |   |   |                          |   |   |                                       |    |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Cumulative effect of change in accounting principle |   |            | — |   |         |   | — |                                 |   |   | —                       |   |   |                                       | — |   |   |   | (15,091 | ) |   |   | 12,961 |   |   |   | (2,130 | ) |
| Issuance of common stock for services               |   |            | — |   |         |   | — |                                 |   |   | 216                           |   |   |                                       | — |   |   |   | 115 |   |   |   | — |   |   |   | 115 |   |
| Stock-based compensation                            |   |            | — |   |         |   | — |                                 |   |   | —                       |   |   |                                       | — |   |   |   | 153 |   |   |   | — |   |   |   | 153 |   |
| Net loss                                            |   |            | — |   |         |   | — |                                 |   |   | —                       |   |   |                                       | — |   |   |   | — |   |   |   | (419 | ) |   |   | (419 | ) |
| Balance, March 31, 2009                             |   |            | 6       |   |         | $      | — |                                 |   |   | 15,430                        |   |   | $                                          | 15      |   |   | $ | 189,995 |   |   | $ | (188,630 | ) |   | $ | 1,380 |   |

----

|                                                                                      |   | Three Months Ended         |    |
|-------------------------------------------------------------------------------------------|--------|----------------------------|---------|
|                                                                                      |   | March 31,                  |    |
|                                                                                      |   | 2009 (Restated)See Note 15 |    |   | 2008 |   |
|                                                                                      |   | (unaudited)                |    |
| Cash flows from operating activities:                                                     |   |                       |    |   |   |   |
| Net loss                                                                                  |   | $                          | (419    | ) |   | $ | (2,674 | ) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |   |                       |    |   |   |   |   |   |
| Depreciation and amortization                                                             |   |                       | 23      |   |   |   | 68 |   |
| Amortization of deferred financing and waiver fees                                        |   |                       | 150     |   |   |   | 448 |   |
| Reduction of provision for sales returns and doubtful accounts                            |   |                       | (114    | ) |   |   | (47 | ) |
| Stock-based compensation                                                                  |   |                       | 153     |   |   |   | 356 |   |
| Issuance of common stock for services                                                     |   |                       | 76      |   |   |   | — |   |
| Change in the fair value of warrant liability                                             |   |                       | 813     |   |   |   | — |   |
| Amortization of discount on notes payable                                                 |   |                       | — |   |   |   | 25 |   |
| Changes in operating assets and liabilities:                                              |   |                       |    |   |   |   |   |   |
| Accounts receivable                                                                       |   |                       | 807     |   |   |   | 329 |   |
| Inventory                                                                                 |   |                       | 160     |   |   |   | (11 | ) |
| Prepaid expenses and other current assets                                                 |   |                       | (398    | )  |   |   | 426 |   |
| Deferred revenue                                                                          |   |                       | (44     | ) |   |   | (79 | ) |
| Accounts payable, accrued compensation, other accrued expenses, and advance payments      |   |                       | (359    | ) |   |   | 830 |   |
| Other current liabilities                                                                 |   |                       | 119     |   |   |   | (244 | ) |
| Net cash provided by (used in) operating activities                                       |   |                       | 967     |   |   |   | (573 | ) |
| Cash flows from investing activities:                                                     |   |                       |    |   |   |   |   |   |
| Purchase of equipment                                                                     |   |                       | (33     | ) |   |   | (231 | ) |
|       Net cash used in investing activities                 |   |                       | (33     | ) |   |   | (231 | ) |
| Cash flows from financing activities:                                                     |   |                       |    |   |   |   |   |   |
| Proceeds from line of credit                                                              |   |                       | — |   |   |   | 700 |   |
| Payments related to deferred financing costs                                              |   |                       | — |   |   |   | (9 | ) |
| Payments of debt                                                                          |   |                       | (1,009  | ) |   |   | (256 | ) |
| Net cash (used in) provided by financing activities                                       |   |                       | (1,009  | )  |   |   | 435 |   |
| Net decrease in cash and cash equivalents                                                 |   |                       | (75     | ) |   |   | (369 | ) |
| Cash and cash equivalents, beginning of period                                            |   |                       | 2,404   |   |   |   | 713 |   |
| Cash and cash equivalents, end of period                                                  |   | $                          | 2,329   |   |   | $ | 344 |   |
|                                                                                      |   |                       |    |   |   |   |   |   |
| Cash paid for interest                                                                    |   | $                          | 38      |   |   | $ | 158 |   |
| Cash paid for taxes                                                                       |   | $                          | 21      |   |   | $ | 10 |   |
|                                                                                      |   |                       |    |   |   |   |   |   |
| Common stock issued for services charged to prepaid expenses                              |   | $                          | 39      |   |   | $ | — |   |

----

----

|                                                                 |   | Additional Paid-In Capital |    |   | Warrant Liability |   |    | Accumulated Deficit |   |
|----------------------------------------------------------------------|--------|----------------------------|---------|--------|-------------------|--------|---------|---------------------|--------|
| Grant date fair value of Warrants                                    |   | $                          | (15,091 | )      |              | $      | 15,091  |                |   | $ |   |   |
| Change in fair value of Warrants outstanding through January 1, 2009 |   |                       |    |   |              |   | (12,961 | )                   |   |   | 12,961 |   |
| Cumulative effect of change in accounting principle                  |   | $                          | (15,091 | )      |              | $      | 2,130   |                |   | $ | 12,961 |   |

----

|              |   |                           |   |   | Fair Value Measurement Using |   |
|-------------------|--------|--------------------------------|--------|--------|------------------------------|--------|
|              |   | Fair Value as ofMarch 31, 2009 |   |   | Level 1                      |   |   | Level 2 |   |   | Level 3 |   |
|              |   |                           |   |   |                         |   |   |   |   |   |   |   |
| Warrant liability |   | $                              | 2,943  |   |                         | $      | — |   |   | $ | — |   |   | $ | 2,943 |   |

| Balance as of January 1, 2009    |   | $      | 2,130 |   |
|----------------------------------|--------|--------|-------|--------|
| Change in fair value of warrants |   |   | 828   |   |
| Fair value of expired warrants   |   |   | (15   | )      |
| Balance as of March 31, 2009     |   | $      | 2,943 |   |

|                      |   | March 31, 2009 |             |   | January 1, 2009 |   |
|---------------------------|--------|----------------|------------------|--------|-----------------|--------|
| Risk-free interest rate   |   |           | 0.57% - 1.67     | %      |            |   | 0.11% - 1.55 | % |
| Expected volatility       |   |           | 96.1             | %      |            |   | 94.4 | % |
| Expected life ( in years) |   |           | 1.0 – 4.75 |   |            |   | 0.02 - 5.0 |   |
| Expected dividend yield   |   |           | 0                | %      |            |   | 0 | % |

|                                 |   | March 31,2009 (unaudited) |   |   | December 31, 2008 |   |
|--------------------------------------|--------|--------------------------------|--------|--------|-------------------|--------|
| Accounts receivable                  |   | $                              | 3,692  |   |              | $      | 4,500 |   |
| Less allowance for doubtful accounts |   |                           | (742   | )      |              |   | (857 | ) |
| Net receivables                 |   | $                              | 2,950  |   |              | $      | 3,643 |   |

----

|                                       |   | Three Months EndedMarch 31, 2009 |    |   | Three Months EndedMarch 31, 2008 |   |
|--------------------------------------------|--------|----------------------------------|---------|--------|----------------------------------|--------|
|                                       |   | Loss                             |    |   | Shares                           |   |   | Per Share Amount |   |   | Loss |   |   | Shares |   |   | Per Share Amount |   |
| Basic EPS                                  |   |                             |    |   |                             |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Loss allocated to common shares            |   | $                                | (419    | )      |                             |   | 15,860,517 |   |   | $ | (0.03 | ) |   | $ | (2,674 | ) |   |   | 12,620,900 |   |   | $ | (0.21 | ) |
| Loss allocated to participating securities |   | $                                | — |   |                             |   |   |   |   |   |   |   |   | $ | — |   |   |   |   |   |   |   |   |   |
| Net loss                                   |   | $                                | (419    | )      |                             |   |   |   |   |   |   |   |   | $ | (2,674 | ) |   |   |   |   |   |   |   |   |
| Diluted potential common shares            |   |                             |    |   |                             |   | — |   |   |   |   |   |   |   |   |   |   |   | — |   |   |   |   |   |
| Diluted EPS                                |   |                             |    |   |                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                   |   | $                                | (419    | )      |                             |   | 15,860,517 |   |   | $ | (0.03 | ) |   | $ | (2,674 | ) |   |   | 12,620,900 |   |   | $ | (0.21 | ) |

|                 |   | March 31,2009 (unaudited) |   |   | December 31, 2008 |   |
|----------------------|--------|--------------------------------|--------|--------|-------------------|--------|
| Raw materials   |   | $                              | 1,085  |   |              | $      | 1,109 |   |
| Work in process      |   |                           | 163    |   |              |   | 280 |   |
| Finished goods  |   |                           | 966    |   |              |   | 985 |   |
| Total inventory      |   | $                              | 2,214  |   |              | $      | 2,374 |   |

----

|                                            |   | March 31,2009 (unaudited) |    |   | December 31, 2008 |   |
|-------------------------------------------------|--------|--------------------------------|---------|--------|-------------------|--------|
| Vendor prepayments                              |   | $                              | 466     |   |              | $      | 180 |   |
| Other prepaid expenses *                        |   |                           | 767     |   |              |   | 383 |   |
| Other assets                                    |   |                           | — |   |              |   | 233 |   |
| Total prepaid expenses and other current assets |   | $                              | 1,233   |   |              | $      | 796 |   |

|                                                                                    |   | March 31, 2009(unaudited) |   |   | December 31,2008 |   |
|-----------------------------------------------------------------------------------------|--------|---------------------------|--------|--------|------------------|--------|
|       Line of credit, net of deferred debt issuance costs |   | $                         | 632    |   |             | $      | 1,631 |   |
|       Other debt                                          |   |                      | 50     |   |             |   | 60 |   |
| Total debt, net                                                                         |   | $                         | 682    |   |             | $      | 1,691 |   |

|                                |   | Three Months Ended March 31, |   |
|-------------------------------------|--------|------------------------------|--------|
|                                |   | 2009                         |   |   | 2008 |   |
| Cost of revenue                     |   | $                            | 24     |   |   | $ | 52 |   |
| Research and development            |   |                         | 58     |   |   |   | 82 |   |
| Selling, general and administrative |   |                         | 71     |   |   |   | 222 |   |
| Total stock compensation expense    |   | $                            | 153    |   |   | $ | 356 |   |

----

|                           |   | For the Three Months Ended March 31, 2008 |              |
|--------------------------------|--------|-------------------------------------------|-------------------|
| Dividend yield                 |   |                                      | 0                 | % |
| Risk free interest rates       |   |                                      | 2.46 – 2.82 | % |
| Expected  volatility |   |                                      | 90.9 – 92.3 | % |
| Expected term (in years)       |   |                                      | 5                 |   |

|                                             |   | Number of Shares |      |   | Weighted Average Exercise Price |   |   | Weighted Average Remaining Contractual Life (In Years) |   |   | Aggregate Intrinsic Value |   |
|--------------------------------------------------|--------|------------------|-----------|--------|---------------------------------|--------|--------|--------------------------------------------------------|--------|--------|---------------------------|--------|
| Outstanding at January 1, 2009                   |   |             | 1,615,673 |   |                            | $      | 1.63   |                                                   |   |   |                      |   |   |   |
| Options granted                                  |   |             | —   |   |                            |   |   |                                                   |   |   |                      |   |   |   |
| Options exercised                                |   |             | —   |   |                            |   |   |                                                   |   |   |                      |   |   |   |
| Options forfeited                                |   |             | (290      | )      |                            |   | 2.60   |                                                   |   |   |                      |   |   |   |
| Options cancelled                                |   |             | —   |   |                            |   |   |                                                   |   |   |                      |   |   |   |
| Outstanding at March 31, 2009                    |   |             | 1,615,383 |   |                            | $      | 1.63   |                                                   |   |   | 6.18                      |   |   | $ | 2,640 |   |
| Vested or expected to vest at March 31, 2009 (1) |   |             | 1,569,799 |   |                            | $      | 1.50   |                                                   |   |   | 6.18                      |   |   | $ | 2,376 |   |
| Exercisable at March 31, 2009                    |   |             | 1,159,546 |   |                            | $      | 1.80   |                                                   |   |   | 6.34                      |   |   | $ | — |   |

|   |          |   |   |   | Options Outstanding |   |   |   | Options Exercisable                                    |   |
|--------|---------------|--------|--------|--------|---------------------|--------|--------|--------|--------------------------------------------------------|--------|
|   |          |   |   |   | Number Outstanding  |   |   |   | Weighted Average Remaining Contractual Life (In Years) |   |   |   | Weighted Average Exercise Price |   |   |   | NumberExercisable |   |   |   | Weighted Average Exercisable Price |   |
| $      | 0.34 - $0.97  |   |   |   | 759,553             |   |   |   | 7.14                                                   |   |   | $ | 0.80 |   |   |   | 406,620 |   |   | $ | 0.79 |   |
| $      | 1.00 - $1.44  |   |   |   | 388,577             |   |   |   | 8.46                                                   |   |   |   | 1.38 |   |   |   | 358,397 |   |   |   | 1.41 |   |
| $      | 2.60 - $2.70  |   |   |   | 430,053             |   |   |   | 2.74                                                   |   |   |   | 2.61 |   |   |   | 362,059 |   |   |   | 2.61 |   |
| $      | 3.50 - $5.80  |   |   |   | 8,000               |   |   |   | 3.31                                                   |   |   |   | 5.51 |   |   |   | 8,000 |   |   |   | 5.51 |   |
| $      | 6.60 - $22.50 |   |   |   | 29,200              |   |   |   | 2.32                                                   |   |   |   | 10.91 |   |   |   | 24,500 |   |   |   | 10.90 |   |
|   |          |   |   |   | 1,615,383           |   |   |   | 6.18                                                   |   |   | $ | 1.63 |   |   |   | 1,159,546 |   |   | $ | 1.80 |   |

----

----

----

| Warrant Issuance Dates |   | Number of Warrants Outstanding as ofMarch 31, 2009 |      |   | Exercise Price |   | Warrant Expiration Dates |   | Fair Value of Warrants atIssue Date(in thousands) |   |   | Fair Value of Warrants atJanuary 1, 2009(in thousands) |   |   | Fair Value of Warrants atMarch 31, 2009(in thousands) |   |
|------------------------|--------|----------------------------------------------------|-----------|--------|----------------|--------|--------------------------|--------|---------------------------------------------------|--------|--------|--------------------------------------------------------|--------|--------|-------------------------------------------------------|--------|
|                   |   |                                               |      |   |           |   |                     |   |                                              |   |   |                                                   |   |   |                                                  |   |
| January 9, 2004        |   |                                               | —   |   |           | $      | 0.35                     |   | January 8, 2009                                   |   | $      | 3,091                                                  |   |   | $                                                     | 15     |   |   | $ | — |   |
| October 25, 2004       |   |                                               | 650,001   |   |           | $      | 2.50                     |   | April 25, 2010                                    |   |   | 4,738                                                  |   |   |                                                  | 19     |   |   |   | 25 |   |
| July 23, 2007          |   |                                               | 5,390,712 |   |           | $      | 1.03                     |   | July 21, 2011                                     |   |   | 5,031                                                  |   |   |                                                  | 1,120  |   |   |   | 1,519 |   |
| July 23, 2007          |   |                                               | 1,000,000 |   |           | $      | 0.48                     |   | July 21, 2011                                     |   |   | 1,136                                                  |   |   |                                                  | 304    |   |   |   | 395 |   |
| April 2, 2008          |   |                                               | 793,273   |   |           | $      | 1.13                     |   | April 2, 2013                                     |   |   | 561                                                    |   |   |                                                  | 224    |   |   |   | 279 |   |
| December 22, 2008      |   |                                               | 1,875,467 |   |           | $      | 1.03                     |   | December 22, 2013                                 |   |   | 534                                                    |   |   |                                                  | 448    |   |   |   | 725 |   |
|                   |   |                                               |      |   |           |   |                     |   | Total Fair Value                                  |   | $      | 15,091                                                 |   |   | $                                                     | 2,130  |   |   | $ | 2,943 |   |

| Condensed Consolidated Balance Sheet |   | March 31, 2009           |     |   | March 31, 2009 |   |
|--------------------------------------|--------|--------------------------|----------|--------|----------------|--------|
| (in thousands)                       |   | (As previously reported) |     |   | (As restated)  |   |
|                                 |   |                     |     |   |           |   |
| Warrant liability                    |   | $                        | —  |   |           | $      | 2,943 |   |
| Total liabilities                    |   | $                        | 4,720    |   |           | $      | 7,663 |   |
|                                 |   |                     |     |   |           |   |   |   |
| Shareholders’ equity:          |   |                     |     |   |           |   |   |   |
| Additional paid-in capital           |   | $                        | 205,086  |   |           | $      | 189,995 |   |
| Accumulated deficit                  |   | $                        | (200,778 | )      |           | $      | (188,630 | ) |
| Total shareholders’ equity     |   | $                        | 4,323    |   |           | $      | 1,380 |   |

| Condensed Consolidated Statements of Operations |   | Three Months EndedMarch 31, 2009 |       |
|-------------------------------------------------|--------|----------------------------------|------------|
| (in thousands except share and per share data)  |   | (As previously reported)         |       |   | (As restated) |   |
|                                            |   |                             |       |   |   |   |
| Change in fair value of warrant liability       |   | $                                | —    |   |   | $ | (813 | ) |
| Total other expense                             |   | $                                | (174       | ) |   | $ | (987 | ) |
| Net income (loss)                               |   | $                                | 394        |   |   | $ | (419 | ) |
| Income (loss) per share, basic                  |   | $                                | 0.02       |   |   | $ | (0.03 | ) |
| Income (loss) per share, diluted                |   | $                                | 0.02       |   |   | $ | (0.03 | ) |
|                                            |   |                             |       |   |   |   |   |   |
| Weighted average number of shares outstanding:  |   |                             |       |   |   |   |   |   |
|   Basic                               |   |                             | 15,860,517 |   |   |   | 15,860,517 |   |
|   Diluted                             |   |                             | 23,899,255 |   |   |   | 15,860,517 |   |

| Condensed Consolidated Statements of Cash Flows |   | Three Months EndedMarch 31, 2009 |    |
|------------------------------------------------------|--------|----------------------------------|---------|
| (in thousands)                                       |   | (As previously reported)         |    |   | (As restated) |   |
|                                                 |   |                             |    |   |   |   |
| Net income (loss)                                    |   | $                                | 394     |   |   | $ | (419 | ) |
| Change in fair value of warrant liability            |   | $                                | — |   |   | $ | 813 |   |
| Net cash provided by operating activities            |   | $                                | 967     |   |   | $ | 967 |   |

----

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

| ·   | To correct errors in the accounting for certain warrants.  Specifically, we previously classified as equity instruments warrants that should have been classified as derivative liability instruments based on the terms of the warrants and the applicable accounting guidance. |
|--------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | To correct an error in the calculation of earnings per share (“EPS”).  We issued Preferred Stock – Series B which participates in dividends with our common stock; as a result, we should have used the two-class method for calculating EPS. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

Not applicable.

----

 

----

| 31.1                    | Certification by Chief Executive Officer pursuant to Sarbanes Oxley Section 302 (1)         |
|------------------------------|-------------------------------------------------------------------------------------------------------|
|                         |                                                                                                  |
| 31.2               | Certification by Chief Financial Officer pursuant to Sarbanes Oxley Section 302 (1)    |
|                         |                                                                                                  |
| 32.1     | Certification by Chief Executive Officer pursuant to 18 U.S.C. Section 1350 (1)                       |
|               |                                                                                                  |
| 32.2                         | Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (1)                       |

----

|   | eMAGIN CORPORATION |                          |
|--------|--------------------|-------------------------------|
|   |               |                          |   |
|   | By:                | /s/ Andrew G. Sculley    |   |
|   |               | Andrew G. Sculley             |   |
|   |               | Chief Executive Officer       |   |
|   |               | (Principal Executive Officer) |   |

|   |   |                                                       |   |
|--------|--------|------------------------------------------------------------|--------|
|   | By:    | /s/ Paul Campbell                                     |   |
|   |   | Paul Campbell                                              |   |
|   |   | Chief Financial Officer                                    |   |
|   |   | (Chief Accounting Officer and Principal Financial Officer) |   |